Microchip Biotech: Revenue will reach 910 million yuan by 2025, turning losses into profits.

WeChat Bio announced that in the fiscal year 2025, the company achieved a total operating income of 910 million yuan, a year-on-year increase of 38.24%; total profit amounted to 50.8433 million yuan, compared to -96.7119 million yuan in the same period last year; net profit attributable to the parent company was 51.0757 million yuan, compared to -115 million yuan in the same period last year, achieving a turnaround from loss to profit. Sales revenue of seglitide sodium increased by around 122% year-on-year, while sales revenue of sertindole increased by around 16% year-on-year. The company stated that the above financial data are preliminary and unaudited, and the specific information should be referred to the annual report of 2025.